Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Decitabine Plus Cytarabine for Induction of Remission in Newly Diagnosed Elderly AML or High Risk MDS Patients

Kelda Gardner, PA-C, MHS, Elihu H. Estey, MD, Weigang Tong, MD, Robert McCroskey, MD, Roland B. Walter, MD PhD MS, Paul C. Hendrie, MD PhD, Bart L. Scott, MD MS, Andrea M. Perdue, PA-C, Mary-Elizabeth M. Percival, MD MS, Heather A. Smith, PA-C, Cody Hammer, Pamela S. Becker, MD PhD

Blood (2016) 128 (22): 5207.

https://doi.org/10.1182/blood.V128.22.5207.5207

Published: 2016

Journal Articles

Central Nervous System Involvement in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation

Merav Bar, MD, Weigang Tong, Megan Othus, PhD, Keith R Loeb, MD PhD, Elihu H. Estey, MD

Blood (2014) 124 (21): 3941.

https://doi.org/10.1182/blood.V124.21.3941.3941

Published: 2014

Journal Articles

Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia

Shao-Qing Kuang, Hao Bai, Zhi-Hong Fang, Gonzalo Lopez, Hui Yang, Weigang Tong, Zack Z. Wang, Guillermo Garcia-Manero

Blood (2010) 115 (12): 2412–2419.

https://doi.org/10.1182/blood-2009-05-222208

Published: 2010

Includes: Supplemental data

Journal Articles

Epigenetic Inactivation of Notch Signaling Target Genes HES in B Cell Acute Lymphoblastic Leukemia.

Shaoqing Kuang, Patrick Zweidler-McKay, MD, PhD, Hui Yang, Zhi Hong Fang, PhD, Weigang Tong, MD, PhD, Guillermo Garcia-Manero, MD

Blood (2008) 112 (11): 3372.

https://doi.org/10.1182/blood.V112.11.3372.3372

Published: 2008

Journal Articles

Imatinib Frontline Therapy Is Safe and Effective in Patients with Chronic Myeloid Leukemia (CML) with Liver and/or Renal Dysfunction.

Weigang Tong, M.D., Ph.D., Hagop Kantarjian, M.D., Susan O’Brien, M.D., Stefan Faderl, MD, Farhad Ravandi, MBBS, William G Wierda, M.D., Ph.D., Steven Kornblau, M.D., Gautam Borthakur, M.D., Guillermo Garcia-Manero, M.D., Elizabeth Burton, Mary Beth Rios, Jorge Cortes, M.D.

Blood (2008) 112 (11): 2126.

https://doi.org/10.1182/blood.V112.11.2126.2126

Published: 2008

Journal Articles

The Combination of a Histone Deacetylase (HDAC) Inhibitor with the BCL-2 Inhibitor GX15-070 Has Synergistic Antileukemia Effect by Inducing Both Apoptotic and Autophagic Pathways.

Yue Wei, PhD, Tapan Kadia, MD, Weigang Tong, MD, PhD, Susan O’Brien, MD, Jean Viallet, MD, Guillermo Garcia-Manero, MD

Blood (2008) 112 (11): 1633.

https://doi.org/10.1182/blood.V112.11.1633.1633

Published: 2008

Journal Articles

Antileukemia Activity of JNJ-26481585, a Potent Second-Generation Histone Deacetylase Inhibitor

Weigang Tong, M.D., Ph.D., Yue Wei, Ph.D., William Stevenson, M.D., Ph.D., Shao-Qing Kuang, M.D., Ph.D., Janine Arts, Ph.D., Guillermo Garcia-Manero, M.D.

Blood (2008) 112 (11): 2631.

https://doi.org/10.1182/blood.V112.11.2631.2631

Published: 2008

Journal Articles

Identification of Multiple Promoter Associated CpG Islands Commonly Methylated in Both Acute Lymphocytic Leukemia (ALL) and Chronic Lymphocytic Leukemia(CLL) Using Novel Genome-Wide Microarray Technique: Implications for Common Primordial Molecular Pathways in Lymphoid Leukemias.

Weigang Tong, MD, PhD, Shao-Qing Kuang, MD, PhD, William Wierda, MD, PhD, Michael J. Keating, MD, Guillermo Garcia-Manero, MD

Blood (2008) 112 (11): 2263.

https://doi.org/10.1182/blood.V112.11.2263.2263

Published: 2008

Journal Articles

Genome-Wide Identification of Aberrant Promoter Associated CpG Island Methylation in Acute Lymphoblastic Leukemia.

Shao-qing Kuang, MD, PhD, Weigang Tong, MD, PhD, Hui Yang, MD, PhD, Mathew K. Lee, Zhi-Hong Fang, PhD, Jeroslav Jelinek, MD, PhD, Jean-Pierre Issa, MD, Guillermo Garcia-Manero, MD

Blood (2007) 110 (11): 2127.

https://doi.org/10.1182/blood.V110.11.2127.2127

Published: 2007

Journal Articles

Eph Receptor Tyrosine Kinases and Ephrin Ligands Are Epigenetically Inactivated in Acute Lymphoblastic Leukemia and Are Potential New Tumor Suppressor Genes in Human Leukemia.

Shao-qing Kuang, MD, PhD, Zhi-Hong Fang, PhD, Gonzalo Lopez, Weigang Tong, MD, PhD, Hui Yang, MD, PhD, Guillermo Garcia-Manero, MD

Blood (2007) 110 (11): 2128.

https://doi.org/10.1182/blood.V110.11.2128.2128

Published: 2007

Journal Articles

Analysis of Class I and II Histone Deacetylase Fails To Identify a Human Leukemia Specific Expression Profile.

Guillermo Garcia-Manero, MD, Andy S. Quesada, MD, PhD, Shirisha Maddipoti, MD, Shaoqing Kuang, MD, Weigang Tong, MD, William G. Wierda, MD, Carlos M. Bueso-Ramos, MD, Hui Yang, MD

Blood (2007) 110 (11): 2130.

https://doi.org/10.1182/blood.V110.11.2130.2130

Published: 2007

Journal Articles

Significant Clinical Activity of the Combination of 5-Azacytidine, Valproic Acid and All-Trans Retinoic (ATRA) Acid in Leukemia: Results of a Phase I/II Study.

Andres O. Soriano, MD, Hui Yang, MD, Weigang Tong, MD, Stefan Faderl, MD, William Wierda, MD, Michael Andreeff, MD, Zeev Estrov, MD, Souzanne Ouzounian, MD, Jonathan Clavell, Hagop Kantarjian, MD, Jean-Pierre Issa, MD, Guillermo Garcia-Manero, MD

Blood (2006) 108 (11): 160.

https://doi.org/10.1182/blood.V108.11.160.160

Published: 2006

Journal Articles

Frequency of NUP214-ABL1 Oncogene in Patients with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Analysis of the Activity of Imatinib and Nilotinib in NUP214-ABL1-Expressing T-ALL Cell Lines.

Alfonso Quintas-Cardama, MD, Weigang Tong, Taghi Manshouri, Jan Cools, PhD, D. Gary Gilliland, MD PhD, Hagop M. Kantarjian, MD, Jorge Cortes, MD, Guillermo Garcia-Manero, MD

Blood (2006) 108 (11): 710.

https://doi.org/10.1182/blood.V108.11.710.710

Published: 2006

NARROW

Decitabine Plus Cytarabine for Induction of Remission in Newly Diagnosed Elderly AML or High Risk MDS Patients

Central Nervous System Involvement in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation

Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia

Epigenetic Inactivation of Notch Signaling Target Genes HES in B Cell Acute Lymphoblastic Leukemia.

Imatinib Frontline Therapy Is Safe and Effective in Patients with Chronic Myeloid Leukemia (CML) with Liver and/or Renal Dysfunction.

The Combination of a Histone Deacetylase (HDAC) Inhibitor with the BCL-2 Inhibitor GX15-070 Has Synergistic Antileukemia Effect by Inducing Both Apoptotic and Autophagic Pathways.

Antileukemia Activity of JNJ-26481585, a Potent Second-Generation Histone Deacetylase Inhibitor

Identification of Multiple Promoter Associated CpG Islands Commonly Methylated in Both Acute Lymphocytic Leukemia (ALL) and Chronic Lymphocytic Leukemia(CLL) Using Novel Genome-Wide Microarray Technique: Implications for Common Primordial Molecular Pathways in Lymphoid Leukemias.

Genome-Wide Identification of Aberrant Promoter Associated CpG Island Methylation in Acute Lymphoblastic Leukemia.

Eph Receptor Tyrosine Kinases and Ephrin Ligands Are Epigenetically Inactivated in Acute Lymphoblastic Leukemia and Are Potential New Tumor Suppressor Genes in Human Leukemia.

Analysis of Class I and II Histone Deacetylase Fails To Identify a Human Leukemia Specific Expression Profile.

Significant Clinical Activity of the Combination of 5-Azacytidine, Valproic Acid and All-Trans Retinoic (ATRA) Acid in Leukemia: Results of a Phase I/II Study.

Frequency of NUP214-ABL1 Oncogene in Patients with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Analysis of the Activity of Imatinib and Nilotinib in NUP214-ABL1-Expressing T-ALL Cell Lines.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only